Theseus Pharmaceuticals Statistics
Total Valuation
COSO has a market cap or net worth of $210.62 million. The enterprise value is $182.08 million.
Important Dates
The last earnings date was Monday, July 28, 2025, after market close.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
COSO has 10.28 million shares outstanding. The number of shares has increased by 6.29% in one year.
| Current Share Class | 10.14M |
| Shares Outstanding | 10.28M |
| Shares Change (YoY) | +6.29% |
| Shares Change (QoQ) | -0.28% |
| Owned by Insiders (%) | 13.82% |
| Owned by Institutions (%) | 7.10% |
| Float | 3.05M |
Valuation Ratios
The trailing PE ratio is 8.82 and the forward PE ratio is 8.63.
| PE Ratio | 8.82 |
| Forward PE | 8.63 |
| PS Ratio | 2.80 |
| Forward PS | n/a |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 7.40 |
| EV / Sales | 2.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.63%.
| Return on Equity (ROE) | 12.63% |
| Return on Assets (ROA) | 1.13% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $419,391 |
| Profits Per Employee | $137,447 |
| Employee Count | 179 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, COSO has paid $5.79 million in taxes.
| Income Tax | 5.79M |
| Effective Tax Rate | 19.06% |
Stock Price Statistics
The stock price has increased by +13.20% in the last 52 weeks. The beta is 0.10, so COSO's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +13.20% |
| 50-Day Moving Average | 20.76 |
| 200-Day Moving Average | 20.69 |
| Relative Strength Index (RSI) | 42.12 |
| Average Volume (20 Days) | 23,539 |
Short Selling Information
The latest short interest is 6,843, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 6,843 |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.07% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, COSO had revenue of $75.07 million and earned $24.60 million in profits. Earnings per share was $2.32.
| Revenue | 75.07M |
| Gross Profit | 75.07M |
| Operating Income | 31.78M |
| Pretax Income | n/a |
| Net Income | 24.60M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $2.32 |
Full Income StatementBalance Sheet
The company has $43.29 million in cash and $14.75 million in debt, giving a net cash position of $28.54 million or $2.78 per share.
| Cash & Cash Equivalents | 43.29M |
| Total Debt | 14.75M |
| Net Cash | 28.54M |
| Net Cash Per Share | $2.78 |
| Equity (Book Value) | 209.37M |
| Book Value Per Share | 20.37 |
| Working Capital | -1.72B |
Full Balance SheetMargins
| Gross Margin | n/a |
| Operating Margin | 42.33% |
| Pretax Margin | 40.49% |
| Profit Margin | 32.77% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
